303 followers
RT @HeoroCom: #Model: #costUtility of #eculizumab for #PNH accounting for #opportunityCosts, Canada: $2.13m/QALY #RareDiseaseDay https://t.…
RT @HeoroCom: #Model: #costUtility of #eculizumab for #PNH accounting for #opportunityCosts, Canada: $2.13m/QALY #RareDiseaseDay https://t.…
#Model: #costUtility of #eculizumab for #PNH accounting for #opportunityCosts, Canada: $2.13m/QALY #RareDiseaseDay https://t.co/328bSZk9Fc
Opportunity cost of funding drugs for rare diseases: the cost-effectiveness of eculizumab in pa... http://t.co/ExUVveKS3g #MedHuérfanos
. @wittykidney @docthahir @LangoteAmit For PNH: cost of eculizumab needs to be 98.5% lower to be cost-effective! http://t.co/LjCuJKssfF